Related Experiment Videos

Truncated erythropoietin receptor in a murine erythroleukemia cell line

T Bittorf1, S J Busfield, S P Klinken

  • 1Department of Biochemistry, University of Western Australia, Nedlands.

Insights

Friend spleen focus forming virus infection causes enlarged erythropoietin receptor mRNA in F4N cells. This results in a truncated protein, yet F4N cells proliferate, indicating altered erythropoietin receptor function.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Virology

Background:

  • The Friend spleen focus forming virus (SFFV) produces an envelope glycoprotein that interacts with the erythropoietin receptor (EpoR).
  • Murine erythroleukemic cell lines F4N and 707, and the J2E erythroid line, were utilized to study EpoR in Friend virus-transformed cells.

Purpose of the Study:

  • To investigate the molecular alterations of the erythropoietin receptor in Friend virus-transformed murine erythroleukemic cell lines.
  • To compare the erythropoietin receptor mRNA and protein products in F4N cells with those in 707 and J2E cell lines.

Main Methods:

  • Reverse transcriptase PCR (RT-PCR) was employed to determine erythropoietin receptor transcript size.
  • Erythropoietin receptor cDNAs were sequenced.
  • Protein products were analyzed using Western blotting and immunoprecipitation.

Main Results:

  • The F4N cell line exhibited an enlarged erythropoietin receptor mRNA, unlike the normal-sized transcripts in 707 and J2E cells.
  • Sequence analysis revealed intron retention in the F4N erythropoietin receptor mRNA, leading to a premature stop codon and a truncated protein (37 kDa) lacking most of its cytoplasmic domain.
  • Despite the truncated receptor, F4N cells continued to proliferate.

Conclusions:

  • Intron retention in erythropoietin receptor mRNA processing in F4N cells results in a non-functional protein with a severely truncated cytoplasmic domain.
  • The proliferation of F4N cells despite the defective erythropoietin receptor suggests alternative signaling pathways or mechanisms contributing to erythroleukemia.

Related Concept Videos